PREDICTION OF 5-YEAR SURVIVAL OF NON-SMALL CELL LUNG CANCER PATIENTS WITH STAGE III AFTER COMPLETE RESECTIONS

1. PREDICTION OF 5-YEAR SURVIVAL OF NON-SMALL CELL LUNG CANCER PATIENTS WITH STAGE III AFTER COMPLETE RESECTIONS Oleg Kshivets, MD, PhD Department of Surgery, Siauliai Cancer Center, Siauliai, Lithuania 2004 ASCO Annual Meeting, New Orleans, Louisiana, the USA, June 3-8, 2004

7. Combined & E xtensive R adical P rocedures with R esection of P ericardium, L eft A trium, A orta, V ena C ava S uperior, V ena A zygos, C arina, Trachea, D iaphragm, C hest W all , Ribs, etc…..……………………. 67 Sistematic Mediastinal Lymph Node-N2 Dissection………….. 139

13. Product-Limit (Kaplan-Maier) Analysis Results in Prediction of Lung Cancer Patients Survival with Stage III after Complete Resections (n=139) Graph of Survival Times vs. Cum. Proportion Surviving

14. Cumulative Proportion Lung Cancer Patients Surviving (Kaplan-Meier) (n=139)

15. Cumulative Proportion Lung Cancer Patients Surviving (Kaplan-Meier)

16. Results of Multivariate Proportional Hazard Cox Regression Analysis:

17. Results of Multifactor Analysis in Prediction of Lung Cancer Patients Survival with Stage IIIA & IIIB (n=139)

20. Results of Clustering in Prediction of Lung Cancer Patients 5-Year Survival (n=131)

22. Results of Correspondence Analysis in Prediction of Lung Cancer Patients Survival with Stage III (n=131)

23. Results of Bootstrap Resampling in Prediction of 5-Year Survival of Lung Cancer Patients with Stage III (n=131; subsamplings=935)

24. Results of Bootstrap Resampling in Prediction of 5-Year Survival of Lung Cancer Patients with Stage III (n=131; subsamplings=935)

30. Lymphocyte & Monocyte Circuit in Prediction of Lung Cancer Patients Survival with Stage III (n=131)

31. Ratio of Segmented Neutrophile and Cancer Cell Populations & Blood Glucose Level in Prediction of Lung Cancer Patients Survival with Stage III (n=131)

32. Weight & Prothrombin Index in Prediction of Lung Cancer Patients Survival with Stage III (n=131)

33. Significant Networks between Clinicopathologic, Biochemic, Hemostasis & Hematologic Data and 5-Year Survival of Lung cancer Patients with Stage III (n=131)

34. Results of Monte Carlo Simulation in Prediction of Lung Cancer Patients Survival with Stage III (n=131)

35. SEPATH Networks in Prediction of Lung Cancer Patients Survival with Stage III (n=131)

36. Holling-Tenner Models of Alive Supersystem “Lung Cancer-Cytotoxic Cell Population ”

37. Lung Cancer Dynamics